Your browser doesn't support javascript.
loading
Intracellular ESAT-6: A new biomarker for Mycobacterium tuberculosis infection.
Poulakis, Nikolaos; Gritzapis, Angelos D; Ploussi, Maria; Leventopoulos, Michail; Papageorgiou, Chrysovalantis V; Anastasopoulos, Andreas; Constantoulakis, Pantelis; Karabela, Simona; Vogiatzakis, Evangelos; Tsilivakos, Vassilis.
Afiliação
  • Poulakis N; Department of Pulmonary Medicine, Locus Medicus S.A., Athens, Greece.
  • Gritzapis AD; Laboratory of Cellular Biology and Immunology, Locus Medicus S.A., Athens, Greece.
  • Ploussi M; Laboratory of Cellular Biology and Immunology, Locus Medicus S.A., Athens, Greece.
  • Leventopoulos M; Department of Molecular Pathology and Genetics, Locus Medicus S.A., Athens, Greece.
  • Papageorgiou CV; Laboratory of Cellular Biology and Immunology, Locus Medicus S.A., Athens, Greece.
  • Anastasopoulos A; Department of Pulmonary Medicine, Locus Medicus S.A., Athens, Greece.
  • Constantoulakis P; 1st Department of Pulmonary Medicine, Sotiria Hospital of Chest Diseases, Athens, Greece.
  • Karabela S; Department of Molecular Pathology and Genetics, Locus Medicus S.A., Athens, Greece.
  • Vogiatzakis E; Microbiology Department, National Reference Laboratory for Mycobacteria, Sotiria Hospital of Chest Diseases, Athens, Greece.
  • Tsilivakos V; Microbiology Department, National Reference Laboratory for Mycobacteria, Sotiria Hospital of Chest Diseases, Athens, Greece.
Cytometry B Clin Cytom ; 90(3): 312-4, 2016 05.
Article em En | MEDLINE | ID: mdl-25545352
BACKGROUND: Early secreted antigenic target 6 (ESAT-6) is a virulent factor of Mycobacterium tuberculosis (MTB). The identification of intracellular (i/c) ESAT-6 in host cells would be a direct marker of MTB infection. We developed a method to detect i/cESAT-6 by flow cytometry. The aim of this study is to investigate the expression of i/cESAT-6 in the host cells of individuals with MTB infection. METHODS: The expression of i/cESAT-6 was examined in the blood of 58 active TB patients, in 10 naïve to TB infection controls, in 17 patients who completed anti-TB treatment, and in 56 close contacts with an index TB case. Additionally, it was examined in the sputum of 12 active TB patients. RESULTS: The i/cESAT-6 was positively detected in the blood of 52 out of 58 (90%) active TB patients. All naïve to TB infection controls were negative. Three out of 17 (18%) patients at the end of anti-TB treatment were positive. Twenty-six out of 56 (46%) close contacts tested positive. The i/cESAT-6 was detected in all culture positive TB sputum specimens. CONCLUSIONS: The i/cESAT-6 is a promising biomarker of MTB infection that could be used in the evaluation of active TB patients and in the diagnosis of latent TB infection. Further studies are needed to validate its potential diagnostic role. © 2014 International Clinical Cytometry Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escarro / Proteínas de Bactérias / Citometria de Fluxo / Mycobacterium tuberculosis / Antígenos de Bactérias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escarro / Proteínas de Bactérias / Citometria de Fluxo / Mycobacterium tuberculosis / Antígenos de Bactérias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos